{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-22-023445","form_type":"8-K","ticker":"PPCB","cik":"0001517681","company_name":"Propanc Biopharma, Inc.","filed_at":"2022-08-18T23:59:59+00:00","discovered_at":"2026-05-14T18:03:55.998225+00:00","generated_at":"2026-06-23T22:48:51.828822+00:00","sec_items":["1.01","2.03","3.02","9.01"],"event_type":"debt","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Propanc Biopharma raises $203K via convertible notes with dilutive conversion terms","bullets":["Entered convertible note agreements with GS Capital ($93K principal, net $88K after $5K OID) and ONE44 ($110K principal, net $100K after $10K OID).","Notes bear interest at 8% (GS) and 10% (ONE44), mature in one year (Aug 2023).","Conversion price for GS note fixed at $0.0028/share, dropping to $0.0013 if stock trades under $0.002 for 5 days; ONE44 at 65% of lowest bid.","Prepayment premiums range from 110%-130% (GS) and 120%-135% (ONE44) of face value plus interest, within 180 days.","Proceeds used for general working capital; notes are convertible into common stock with 4.99% beneficial ownership cap."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-22-023445","json":"https://secwatch.observer/filing/0001493152-22-023445.json","markdown":"https://secwatch.observer/filing/0001493152-22-023445.md","text":"https://secwatch.observer/filing/0001493152-22-023445.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1517681/000149315222023445/0001493152-22-023445-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1517681/000149315222023445/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-23T22:48:51.828822+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}